nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—CYP2C19—Cholecalciferol—psoriasis	0.105	0.359	CbGbCtD
Methsuximide—CYP2C19—Prednisone—psoriasis	0.0729	0.249	CbGbCtD
Methsuximide—CYP2C19—Cyclosporine—psoriasis	0.0691	0.236	CbGbCtD
Methsuximide—CYP2C19—Dexamethasone—psoriasis	0.0455	0.155	CbGbCtD
Methsuximide—Urticaria—Methoxsalen—psoriasis	0.00327	0.00462	CcSEcCtD
Methsuximide—Headache—Fluocinonide—psoriasis	0.00327	0.00462	CcSEcCtD
Methsuximide—Somnolence—Calcitriol—psoriasis	0.00326	0.00461	CcSEcCtD
Methsuximide—Hiccups—Prednisone—psoriasis	0.00322	0.00455	CcSEcCtD
Methsuximide—Haematuria—Mycophenolic acid—psoriasis	0.00321	0.00453	CcSEcCtD
Methsuximide—Decreased appetite—Calcitriol—psoriasis	0.00319	0.00451	CcSEcCtD
Methsuximide—Constipation—Calcitriol—psoriasis	0.00314	0.00443	CcSEcCtD
Methsuximide—Nausea—Beclomethasone—psoriasis	0.00313	0.00442	CcSEcCtD
Methsuximide—Anorexia—Acitretin—psoriasis	0.00311	0.0044	CcSEcCtD
Methsuximide—Psychotic disorder—Hydrocortisone—psoriasis	0.00307	0.00433	CcSEcCtD
Methsuximide—Proteinuria—Methotrexate—psoriasis	0.00306	0.00433	CcSEcCtD
Methsuximide—Protein urine present—Methotrexate—psoriasis	0.00302	0.00427	CcSEcCtD
Methsuximide—Gastrointestinal pain—Calcitriol—psoriasis	0.003	0.00424	CcSEcCtD
Methsuximide—Irritability—Hydrocortisone—psoriasis	0.003	0.00424	CcSEcCtD
Methsuximide—Insomnia—Acitretin—psoriasis	0.00295	0.00417	CcSEcCtD
Methsuximide—Urticaria—Calcitriol—psoriasis	0.00291	0.00412	CcSEcCtD
Methsuximide—Somnolence—Acitretin—psoriasis	0.0029	0.0041	CcSEcCtD
Methsuximide—Abdominal pain—Calcitriol—psoriasis	0.0029	0.0041	CcSEcCtD
Methsuximide—Decreased appetite—Acitretin—psoriasis	0.00284	0.00401	CcSEcCtD
Methsuximide—Pancytopenia—Mycophenolate mofetil—psoriasis	0.00283	0.004	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Acitretin—psoriasis	0.00282	0.00398	CcSEcCtD
Methsuximide—Leukopenia—Hydroxyurea—psoriasis	0.00281	0.00397	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.00281	0.00397	CcSEcCtD
Methsuximide—Constipation—Acitretin—psoriasis	0.00279	0.00394	CcSEcCtD
Methsuximide—Weight decreased—Cyclosporine—psoriasis	0.00276	0.0039	CcSEcCtD
Methsuximide—Dizziness—Methoxsalen—psoriasis	0.00272	0.00385	CcSEcCtD
Methsuximide—Weight decreased—Mycophenolate mofetil—psoriasis	0.00269	0.00381	CcSEcCtD
Methsuximide—Feeling abnormal—Acitretin—psoriasis	0.00269	0.0038	CcSEcCtD
Methsuximide—Gastrointestinal pain—Acitretin—psoriasis	0.00267	0.00377	CcSEcCtD
Methsuximide—Psychotic disorder—Betamethasone—psoriasis	0.00262	0.0037	CcSEcCtD
Methsuximide—Psychotic disorder—Dexamethasone—psoriasis	0.00262	0.0037	CcSEcCtD
Methsuximide—Haematuria—Cyclosporine—psoriasis	0.0026	0.00367	CcSEcCtD
Methsuximide—Rash—Methoxsalen—psoriasis	0.00259	0.00367	CcSEcCtD
Methsuximide—Dermatitis—Methoxsalen—psoriasis	0.00259	0.00366	CcSEcCtD
Methsuximide—Urticaria—Acitretin—psoriasis	0.00259	0.00366	CcSEcCtD
Methsuximide—Tension—Mycophenolic acid—psoriasis	0.00258	0.00365	CcSEcCtD
Methsuximide—Abdominal pain—Acitretin—psoriasis	0.00258	0.00365	CcSEcCtD
Methsuximide—Headache—Methoxsalen—psoriasis	0.00258	0.00364	CcSEcCtD
Methsuximide—Irritability—Betamethasone—psoriasis	0.00256	0.00362	CcSEcCtD
Methsuximide—Irritability—Dexamethasone—psoriasis	0.00256	0.00362	CcSEcCtD
Methsuximide—Nervousness—Mycophenolic acid—psoriasis	0.00255	0.00361	CcSEcCtD
Methsuximide—Haematuria—Mycophenolate mofetil—psoriasis	0.00253	0.00358	CcSEcCtD
Methsuximide—Diarrhoea—Calcitriol—psoriasis	0.00251	0.00355	CcSEcCtD
Methsuximide—Vision blurred—Mycophenolic acid—psoriasis	0.00248	0.0035	CcSEcCtD
Methsuximide—Weight decreased—Hydrocortisone—psoriasis	0.00245	0.00347	CcSEcCtD
Methsuximide—Nausea—Methoxsalen—psoriasis	0.00244	0.00346	CcSEcCtD
Methsuximide—Anorexia—Hydroxyurea—psoriasis	0.00244	0.00345	CcSEcCtD
Methsuximide—Leukopenia—Mycophenolic acid—psoriasis	0.00235	0.00333	CcSEcCtD
Methsuximide—Vomiting—Calcitriol—psoriasis	0.00233	0.0033	CcSEcCtD
Methsuximide—Rash—Calcitriol—psoriasis	0.00231	0.00327	CcSEcCtD
Methsuximide—Dermatitis—Calcitriol—psoriasis	0.00231	0.00327	CcSEcCtD
Methsuximide—Headache—Calcitriol—psoriasis	0.0023	0.00325	CcSEcCtD
Methsuximide—Psychotic disorder—Prednisone—psoriasis	0.00228	0.00322	CcSEcCtD
Methsuximide—Somnolence—Hydroxyurea—psoriasis	0.00228	0.00322	CcSEcCtD
Methsuximide—Diarrhoea—Acitretin—psoriasis	0.00223	0.00316	CcSEcCtD
Methsuximide—Irritability—Prednisone—psoriasis	0.00223	0.00315	CcSEcCtD
Methsuximide—Decreased appetite—Hydroxyurea—psoriasis	0.00223	0.00315	CcSEcCtD
Methsuximide—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.00223	0.00315	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00221	0.00313	CcSEcCtD
Methsuximide—Constipation—Hydroxyurea—psoriasis	0.00219	0.0031	CcSEcCtD
Methsuximide—Nausea—Calcitriol—psoriasis	0.00218	0.00308	CcSEcCtD
Methsuximide—Confusional state—Mycophenolic acid—psoriasis	0.00216	0.00306	CcSEcCtD
Methsuximide—Dizziness—Acitretin—psoriasis	0.00216	0.00305	CcSEcCtD
Methsuximide—Dizziness—Fluocinolone Acetonide—psoriasis	0.00215	0.00304	CcSEcCtD
Methsuximide—Feeling abnormal—Hydroxyurea—psoriasis	0.00211	0.00298	CcSEcCtD
Methsuximide—Weight decreased—Betamethasone—psoriasis	0.0021	0.00296	CcSEcCtD
Methsuximide—Weight decreased—Dexamethasone—psoriasis	0.0021	0.00296	CcSEcCtD
Methsuximide—Tension—Cyclosporine—psoriasis	0.00209	0.00295	CcSEcCtD
Methsuximide—Vomiting—Acitretin—psoriasis	0.00207	0.00293	CcSEcCtD
Methsuximide—Vomiting—Fluocinolone Acetonide—psoriasis	0.00207	0.00292	CcSEcCtD
Methsuximide—Nervousness—Cyclosporine—psoriasis	0.00207	0.00292	CcSEcCtD
Methsuximide—Rash—Acitretin—psoriasis	0.00206	0.00291	CcSEcCtD
Methsuximide—Dermatitis—Acitretin—psoriasis	0.00206	0.00291	CcSEcCtD
Methsuximide—Rash—Fluocinolone Acetonide—psoriasis	0.00205	0.0029	CcSEcCtD
Methsuximide—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00205	0.0029	CcSEcCtD
Methsuximide—Anorexia—Mycophenolic acid—psoriasis	0.00205	0.00289	CcSEcCtD
Methsuximide—Headache—Acitretin—psoriasis	0.00204	0.00289	CcSEcCtD
Methsuximide—Headache—Fluocinolone Acetonide—psoriasis	0.00204	0.00288	CcSEcCtD
Methsuximide—Tension—Mycophenolate mofetil—psoriasis	0.00204	0.00288	CcSEcCtD
Methsuximide—Nervousness—Mycophenolate mofetil—psoriasis	0.00202	0.00285	CcSEcCtD
Methsuximide—Vision blurred—Cyclosporine—psoriasis	0.002	0.00283	CcSEcCtD
Methsuximide—Insomnia—Mycophenolic acid—psoriasis	0.00194	0.00274	CcSEcCtD
Methsuximide—Nausea—Acitretin—psoriasis	0.00194	0.00274	CcSEcCtD
Methsuximide—Nausea—Fluocinolone Acetonide—psoriasis	0.00193	0.00273	CcSEcCtD
Methsuximide—Somnolence—Mycophenolic acid—psoriasis	0.00191	0.0027	CcSEcCtD
Methsuximide—Leukopenia—Cyclosporine—psoriasis	0.0019	0.00269	CcSEcCtD
Methsuximide—Decreased appetite—Mycophenolic acid—psoriasis	0.00187	0.00264	CcSEcCtD
Methsuximide—Irritability—Methotrexate—psoriasis	0.00186	0.00263	CcSEcCtD
Methsuximide—Leukopenia—Mycophenolate mofetil—psoriasis	0.00186	0.00263	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.00185	0.00262	CcSEcCtD
Methsuximide—Ataxia—Methotrexate—psoriasis	0.00184	0.00259	CcSEcCtD
Methsuximide—Constipation—Mycophenolic acid—psoriasis	0.00183	0.00259	CcSEcCtD
Methsuximide—Weight decreased—Prednisone—psoriasis	0.00183	0.00258	CcSEcCtD
Methsuximide—Vision blurred—Prednisolone—psoriasis	0.00182	0.00258	CcSEcCtD
Methsuximide—Feeling abnormal—Mycophenolic acid—psoriasis	0.00177	0.0025	CcSEcCtD
Methsuximide—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.00175	0.00248	CcSEcCtD
Methsuximide—Diarrhoea—Hydroxyurea—psoriasis	0.00175	0.00248	CcSEcCtD
Methsuximide—Confusional state—Cyclosporine—psoriasis	0.00175	0.00247	CcSEcCtD
Methsuximide—Confusional state—Mycophenolate mofetil—psoriasis	0.00171	0.00241	CcSEcCtD
Methsuximide—Abdominal pain—Mycophenolic acid—psoriasis	0.0017	0.0024	CcSEcCtD
Methsuximide—Dizziness—Hydroxyurea—psoriasis	0.00169	0.00239	CcSEcCtD
Methsuximide—Eosinophilia—Methotrexate—psoriasis	0.00167	0.00236	CcSEcCtD
Methsuximide—Anorexia—Cyclosporine—psoriasis	0.00165	0.00234	CcSEcCtD
Methsuximide—Vomiting—Hydroxyurea—psoriasis	0.00163	0.0023	CcSEcCtD
Methsuximide—Rash—Hydroxyurea—psoriasis	0.00162	0.00228	CcSEcCtD
Methsuximide—Anorexia—Mycophenolate mofetil—psoriasis	0.00161	0.00228	CcSEcCtD
Methsuximide—Dermatitis—Hydroxyurea—psoriasis	0.00161	0.00228	CcSEcCtD
Methsuximide—Headache—Hydroxyurea—psoriasis	0.0016	0.00227	CcSEcCtD
Methsuximide—Pancytopenia—Methotrexate—psoriasis	0.0016	0.00226	CcSEcCtD
Methsuximide—Insomnia—Cyclosporine—psoriasis	0.00157	0.00222	CcSEcCtD
Methsuximide—Somnolence—Cyclosporine—psoriasis	0.00154	0.00218	CcSEcCtD
Methsuximide—Insomnia—Mycophenolate mofetil—psoriasis	0.00153	0.00217	CcSEcCtD
Methsuximide—Nausea—Hydroxyurea—psoriasis	0.00152	0.00215	CcSEcCtD
Methsuximide—Decreased appetite—Cyclosporine—psoriasis	0.00151	0.00213	CcSEcCtD
Methsuximide—Somnolence—Mycophenolate mofetil—psoriasis	0.00151	0.00213	CcSEcCtD
Methsuximide—Drowsiness—Methotrexate—psoriasis	0.0015	0.00213	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Cyclosporine—psoriasis	0.0015	0.00212	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.00149	0.00211	CcSEcCtD
Methsuximide—Constipation—Cyclosporine—psoriasis	0.00148	0.0021	CcSEcCtD
Methsuximide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00147	0.00208	CcSEcCtD
Methsuximide—Anorexia—Hydrocortisone—psoriasis	0.00147	0.00208	CcSEcCtD
Methsuximide—Diarrhoea—Mycophenolic acid—psoriasis	0.00147	0.00208	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.00146	0.00207	CcSEcCtD
Methsuximide—Constipation—Mycophenolate mofetil—psoriasis	0.00145	0.00205	CcSEcCtD
Methsuximide—Haematuria—Methotrexate—psoriasis	0.00143	0.00203	CcSEcCtD
Methsuximide—Feeling abnormal—Cyclosporine—psoriasis	0.00143	0.00202	CcSEcCtD
Methsuximide—Insomnia—Prednisolone—psoriasis	0.00143	0.00202	CcSEcCtD
Methsuximide—Gastrointestinal pain—Cyclosporine—psoriasis	0.00142	0.00201	CcSEcCtD
Methsuximide—Dizziness—Mycophenolic acid—psoriasis	0.00142	0.00201	CcSEcCtD
Methsuximide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.0014	0.00197	CcSEcCtD
Methsuximide—Insomnia—Hydrocortisone—psoriasis	0.0014	0.00197	CcSEcCtD
Methsuximide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00138	0.00196	CcSEcCtD
Methsuximide—Urticaria—Cyclosporine—psoriasis	0.00138	0.00195	CcSEcCtD
Methsuximide—Abdominal pain—Cyclosporine—psoriasis	0.00137	0.00194	CcSEcCtD
Methsuximide—Vomiting—Mycophenolic acid—psoriasis	0.00136	0.00193	CcSEcCtD
Methsuximide—Rash—Mycophenolic acid—psoriasis	0.00135	0.00191	CcSEcCtD
Methsuximide—Dermatitis—Mycophenolic acid—psoriasis	0.00135	0.00191	CcSEcCtD
Methsuximide—Urticaria—Mycophenolate mofetil—psoriasis	0.00135	0.0019	CcSEcCtD
Methsuximide—Headache—Mycophenolic acid—psoriasis	0.00134	0.0019	CcSEcCtD
Methsuximide—Decreased appetite—Hydrocortisone—psoriasis	0.00134	0.0019	CcSEcCtD
Methsuximide—Abdominal pain—Mycophenolate mofetil—psoriasis	0.00134	0.00189	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00133	0.00188	CcSEcCtD
Methsuximide—Vision blurred—Prednisone—psoriasis	0.00133	0.00187	CcSEcCtD
Methsuximide—Insomnia—Triamcinolone—psoriasis	0.00131	0.00186	CcSEcCtD
Methsuximide—Feeling abnormal—Prednisolone—psoriasis	0.0013	0.00184	CcSEcCtD
Methsuximide—Erythema multiforme—Methotrexate—psoriasis	0.00128	0.0018	CcSEcCtD
Methsuximide—Nausea—Mycophenolic acid—psoriasis	0.00127	0.0018	CcSEcCtD
Methsuximide—Feeling abnormal—Hydrocortisone—psoriasis	0.00127	0.0018	CcSEcCtD
Methsuximide—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00126	0.00178	CcSEcCtD
Methsuximide—Anorexia—Betamethasone—psoriasis	0.00126	0.00178	CcSEcCtD
Methsuximide—Anorexia—Dexamethasone—psoriasis	0.00126	0.00178	CcSEcCtD
Methsuximide—Urticaria—Prednisolone—psoriasis	0.00125	0.00177	CcSEcCtD
Methsuximide—Urticaria—Hydrocortisone—psoriasis	0.00123	0.00173	CcSEcCtD
Methsuximide—Abdominal pain—Hydrocortisone—psoriasis	0.00122	0.00172	CcSEcCtD
Methsuximide—Feeling abnormal—Triamcinolone—psoriasis	0.0012	0.00169	CcSEcCtD
Methsuximide—Insomnia—Dexamethasone—psoriasis	0.00119	0.00169	CcSEcCtD
Methsuximide—Insomnia—Betamethasone—psoriasis	0.00119	0.00169	CcSEcCtD
Methsuximide—Diarrhoea—Cyclosporine—psoriasis	0.00119	0.00168	CcSEcCtD
Methsuximide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.00116	0.00164	CcSEcCtD
Methsuximide—Urticaria—Triamcinolone—psoriasis	0.00115	0.00163	CcSEcCtD
Methsuximide—Dizziness—Cyclosporine—psoriasis	0.00115	0.00162	CcSEcCtD
Methsuximide—Decreased appetite—Dexamethasone—psoriasis	0.00115	0.00162	CcSEcCtD
Methsuximide—Decreased appetite—Betamethasone—psoriasis	0.00115	0.00162	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00114	0.00161	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Betamethasone—psoriasis	0.00114	0.00161	CcSEcCtD
Methsuximide—Dizziness—Mycophenolate mofetil—psoriasis	0.00112	0.00158	CcSEcCtD
Methsuximide—Vision blurred—Methotrexate—psoriasis	0.00111	0.00157	CcSEcCtD
Methsuximide—Vomiting—Cyclosporine—psoriasis	0.0011	0.00156	CcSEcCtD
Methsuximide—Rash—Cyclosporine—psoriasis	0.00109	0.00155	CcSEcCtD
Methsuximide—Anorexia—Prednisone—psoriasis	0.00109	0.00155	CcSEcCtD
Methsuximide—Dermatitis—Cyclosporine—psoriasis	0.00109	0.00155	CcSEcCtD
Methsuximide—Headache—Cyclosporine—psoriasis	0.00109	0.00154	CcSEcCtD
Methsuximide—Feeling abnormal—Betamethasone—psoriasis	0.00109	0.00154	CcSEcCtD
Methsuximide—Feeling abnormal—Dexamethasone—psoriasis	0.00109	0.00154	CcSEcCtD
Methsuximide—Gastrointestinal pain—Dexamethasone—psoriasis	0.00108	0.00152	CcSEcCtD
Methsuximide—Gastrointestinal pain—Betamethasone—psoriasis	0.00108	0.00152	CcSEcCtD
Methsuximide—Vomiting—Mycophenolate mofetil—psoriasis	0.00108	0.00152	CcSEcCtD
Methsuximide—Rash—Mycophenolate mofetil—psoriasis	0.00107	0.00151	CcSEcCtD
Methsuximide—Dermatitis—Mycophenolate mofetil—psoriasis	0.00107	0.00151	CcSEcCtD
Methsuximide—Headache—Mycophenolate mofetil—psoriasis	0.00106	0.0015	CcSEcCtD
Methsuximide—Diarrhoea—Hydrocortisone—psoriasis	0.00106	0.00149	CcSEcCtD
Methsuximide—Leukopenia—Methotrexate—psoriasis	0.00105	0.00149	CcSEcCtD
Methsuximide—Urticaria—Betamethasone—psoriasis	0.00105	0.00148	CcSEcCtD
Methsuximide—Urticaria—Dexamethasone—psoriasis	0.00105	0.00148	CcSEcCtD
Methsuximide—Dizziness—Prednisolone—psoriasis	0.00104	0.00148	CcSEcCtD
Methsuximide—Abdominal pain—Betamethasone—psoriasis	0.00104	0.00147	CcSEcCtD
Methsuximide—Abdominal pain—Dexamethasone—psoriasis	0.00104	0.00147	CcSEcCtD
Methsuximide—Insomnia—Prednisone—psoriasis	0.00104	0.00147	CcSEcCtD
Methsuximide—Nausea—Cyclosporine—psoriasis	0.00103	0.00146	CcSEcCtD
Methsuximide—Dizziness—Hydrocortisone—psoriasis	0.00102	0.00144	CcSEcCtD
Methsuximide—Nausea—Mycophenolate mofetil—psoriasis	0.00101	0.00142	CcSEcCtD
Methsuximide—Decreased appetite—Prednisone—psoriasis	0.000998	0.00141	CcSEcCtD
Methsuximide—Rash—Prednisolone—psoriasis	0.000996	0.00141	CcSEcCtD
Methsuximide—Dermatitis—Prednisolone—psoriasis	0.000995	0.00141	CcSEcCtD
Methsuximide—Headache—Prednisolone—psoriasis	0.00099	0.0014	CcSEcCtD
Methsuximide—Constipation—Prednisone—psoriasis	0.000982	0.00139	CcSEcCtD
Methsuximide—Vomiting—Hydrocortisone—psoriasis	0.000981	0.00139	CcSEcCtD
Methsuximide—Rash—Hydrocortisone—psoriasis	0.000973	0.00138	CcSEcCtD
Methsuximide—Dermatitis—Hydrocortisone—psoriasis	0.000972	0.00137	CcSEcCtD
Methsuximide—Confusional state—Methotrexate—psoriasis	0.000967	0.00137	CcSEcCtD
Methsuximide—Headache—Hydrocortisone—psoriasis	0.000966	0.00137	CcSEcCtD
Methsuximide—Dizziness—Triamcinolone—psoriasis	0.000961	0.00136	CcSEcCtD
Methsuximide—Feeling abnormal—Prednisone—psoriasis	0.000946	0.00134	CcSEcCtD
Methsuximide—Gastrointestinal pain—Prednisone—psoriasis	0.000939	0.00133	CcSEcCtD
Methsuximide—Nausea—Prednisolone—psoriasis	0.000938	0.00133	CcSEcCtD
Methsuximide—Vomiting—Triamcinolone—psoriasis	0.000924	0.00131	CcSEcCtD
Methsuximide—Nausea—Hydrocortisone—psoriasis	0.000916	0.0013	CcSEcCtD
Methsuximide—Rash—Triamcinolone—psoriasis	0.000916	0.00129	CcSEcCtD
Methsuximide—Dermatitis—Triamcinolone—psoriasis	0.000915	0.00129	CcSEcCtD
Methsuximide—Anorexia—Methotrexate—psoriasis	0.000914	0.00129	CcSEcCtD
Methsuximide—Urticaria—Prednisone—psoriasis	0.000912	0.00129	CcSEcCtD
Methsuximide—Headache—Triamcinolone—psoriasis	0.00091	0.00129	CcSEcCtD
Methsuximide—Abdominal pain—Prednisone—psoriasis	0.000907	0.00128	CcSEcCtD
Methsuximide—Diarrhoea—Dexamethasone—psoriasis	0.000902	0.00127	CcSEcCtD
Methsuximide—Diarrhoea—Betamethasone—psoriasis	0.000902	0.00127	CcSEcCtD
Methsuximide—Dizziness—Dexamethasone—psoriasis	0.000872	0.00123	CcSEcCtD
Methsuximide—Dizziness—Betamethasone—psoriasis	0.000872	0.00123	CcSEcCtD
Methsuximide—Insomnia—Methotrexate—psoriasis	0.000868	0.00123	CcSEcCtD
Methsuximide—Nausea—Triamcinolone—psoriasis	0.000863	0.00122	CcSEcCtD
Methsuximide—Somnolence—Methotrexate—psoriasis	0.000853	0.00121	CcSEcCtD
Methsuximide—Vomiting—Dexamethasone—psoriasis	0.000838	0.00118	CcSEcCtD
Methsuximide—Vomiting—Betamethasone—psoriasis	0.000838	0.00118	CcSEcCtD
Methsuximide—Decreased appetite—Methotrexate—psoriasis	0.000834	0.00118	CcSEcCtD
Methsuximide—Rash—Dexamethasone—psoriasis	0.000831	0.00117	CcSEcCtD
Methsuximide—Rash—Betamethasone—psoriasis	0.000831	0.00117	CcSEcCtD
Methsuximide—Dermatitis—Betamethasone—psoriasis	0.00083	0.00117	CcSEcCtD
Methsuximide—Dermatitis—Dexamethasone—psoriasis	0.00083	0.00117	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Methotrexate—psoriasis	0.000828	0.00117	CcSEcCtD
Methsuximide—Headache—Dexamethasone—psoriasis	0.000826	0.00117	CcSEcCtD
Methsuximide—Headache—Betamethasone—psoriasis	0.000826	0.00117	CcSEcCtD
Methsuximide—Feeling abnormal—Methotrexate—psoriasis	0.00079	0.00112	CcSEcCtD
Methsuximide—Diarrhoea—Prednisone—psoriasis	0.000785	0.00111	CcSEcCtD
Methsuximide—Gastrointestinal pain—Methotrexate—psoriasis	0.000784	0.00111	CcSEcCtD
Methsuximide—Nausea—Dexamethasone—psoriasis	0.000783	0.00111	CcSEcCtD
Methsuximide—Nausea—Betamethasone—psoriasis	0.000783	0.00111	CcSEcCtD
Methsuximide—Urticaria—Methotrexate—psoriasis	0.000762	0.00108	CcSEcCtD
Methsuximide—Dizziness—Prednisone—psoriasis	0.000759	0.00107	CcSEcCtD
Methsuximide—Abdominal pain—Methotrexate—psoriasis	0.000758	0.00107	CcSEcCtD
Methsuximide—Vomiting—Prednisone—psoriasis	0.00073	0.00103	CcSEcCtD
Methsuximide—Rash—Prednisone—psoriasis	0.000724	0.00102	CcSEcCtD
Methsuximide—Dermatitis—Prednisone—psoriasis	0.000723	0.00102	CcSEcCtD
Methsuximide—Headache—Prednisone—psoriasis	0.000719	0.00102	CcSEcCtD
Methsuximide—Nausea—Prednisone—psoriasis	0.000682	0.000964	CcSEcCtD
Methsuximide—Diarrhoea—Methotrexate—psoriasis	0.000656	0.000928	CcSEcCtD
Methsuximide—Dizziness—Methotrexate—psoriasis	0.000634	0.000897	CcSEcCtD
Methsuximide—Vomiting—Methotrexate—psoriasis	0.00061	0.000862	CcSEcCtD
Methsuximide—Rash—Methotrexate—psoriasis	0.000605	0.000855	CcSEcCtD
Methsuximide—Dermatitis—Methotrexate—psoriasis	0.000604	0.000854	CcSEcCtD
Methsuximide—Headache—Methotrexate—psoriasis	0.000601	0.00085	CcSEcCtD
Methsuximide—Nausea—Methotrexate—psoriasis	0.00057	0.000805	CcSEcCtD
